Global Computer-Aided Drug 麻豆原创 Research Report 2024

Publication ID:

PB506249618

Publication Date:

June 13, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Computer-aided drugs are drugs that are produced based on computer chemistry, through computer simulations, calculations, and budgeting of the relationship between drugs and receptor biomacromolecules, and design and optimization of lead compounds. Computer-aided drug design is actually the optimization and design of lead compounds by simulating and calculating this interaction between receptors and ligands.
The global Computer-Aided Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Computer-Aided Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Computer-Aided Drug.
Report Scope
The Computer-Aided Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Computer-Aided Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Computer-Aided Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
麻豆原创 Positioning Of Vendors
Aaranya Biosciences Pvt. Ltd.
Albany Molecular Research Inc.
Charles River Laboratories International Inc.
Chembio Discovery Inc.
Chemical Computing Group ULC
Compchem Solutions Ltd.
International Business Machines Corp.
Kang Yusheng Information Technology Co. Ltd.
Openeye Scientific Software Inc.
Pharmaron Beijing Co. Ltd.
Segment by Type
Structure Based Drug
Ligand Based Drug
Segment by Application
Oncological Disorders
Neurological Disorders
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Computer-Aided Drug companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Computer-Aided Drug 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Structure Based Drug
1.2.3 Ligand Based Drug
1.3 麻豆原创 by Application
1.3.1 Global Computer-Aided Drug 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Oncological Disorders
1.3.3 Neurological Disorders
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Computer-Aided Drug 麻豆原创 Perspective (2019-2030)
2.2 Computer-Aided Drug Growth Trends by Region
2.2.1 Global Computer-Aided Drug 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Computer-Aided Drug Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Computer-Aided Drug Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Computer-Aided Drug 麻豆原创 Dynamics
2.3.1 Computer-Aided Drug Industry Trends
2.3.2 Computer-Aided Drug 麻豆原创 Drivers
2.3.3 Computer-Aided Drug 麻豆原创 Challenges
2.3.4 Computer-Aided Drug 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Computer-Aided Drug Players by Revenue
3.1.1 Global Top Computer-Aided Drug Players by Revenue (2019-2024)
3.1.2 Global Computer-Aided Drug Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Computer-Aided Drug 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Computer-Aided Drug Revenue
3.4 Global Computer-Aided Drug 麻豆原创 Concentration Ratio
3.4.1 Global Computer-Aided Drug 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Computer-Aided Drug Revenue in 2023
3.5 Computer-Aided Drug Key Players Head office and Area Served
3.6 Key Players Computer-Aided Drug Product Solution and Service
3.7 Date of Enter into Computer-Aided Drug 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Computer-Aided Drug Breakdown Data by Type
4.1 Global Computer-Aided Drug Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Computer-Aided Drug Forecasted 麻豆原创 Size by Type (2025-2030)
5 Computer-Aided Drug Breakdown Data by Application
5.1 Global Computer-Aided Drug Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Computer-Aided Drug Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Computer-Aided Drug 麻豆原创 Size (2019-2030)
6.2 North America Computer-Aided Drug 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Computer-Aided Drug 麻豆原创 Size by Country (2019-2024)
6.4 North America Computer-Aided Drug 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Computer-Aided Drug 麻豆原创 Size (2019-2030)
7.2 Europe Computer-Aided Drug 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Computer-Aided Drug 麻豆原创 Size by Country (2019-2024)
7.4 Europe Computer-Aided Drug 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Computer-Aided Drug 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Computer-Aided Drug 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Computer-Aided Drug 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Computer-Aided Drug 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Computer-Aided Drug 麻豆原创 Size (2019-2030)
9.2 Latin America Computer-Aided Drug 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Computer-Aided Drug 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Computer-Aided Drug 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Computer-Aided Drug 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Computer-Aided Drug 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Computer-Aided Drug 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Computer-Aided Drug 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 麻豆原创 Positioning Of Vendors
11.1.1 麻豆原创 Positioning Of Vendors Company Detail
11.1.2 麻豆原创 Positioning Of Vendors Business Overview
11.1.3 麻豆原创 Positioning Of Vendors Computer-Aided Drug Introduction
11.1.4 麻豆原创 Positioning Of Vendors Revenue in Computer-Aided Drug Business (2019-2024)
11.1.5 麻豆原创 Positioning Of Vendors Recent Development
11.2 Aaranya Biosciences Pvt. Ltd.
11.2.1 Aaranya Biosciences Pvt. Ltd. Company Detail
11.2.2 Aaranya Biosciences Pvt. Ltd. Business Overview
11.2.3 Aaranya Biosciences Pvt. Ltd. Computer-Aided Drug Introduction
11.2.4 Aaranya Biosciences Pvt. Ltd. Revenue in Computer-Aided Drug Business (2019-2024)
11.2.5 Aaranya Biosciences Pvt. Ltd. Recent Development
11.3 Albany Molecular Research Inc.
11.3.1 Albany Molecular Research Inc. Company Detail
11.3.2 Albany Molecular Research Inc. Business Overview
11.3.3 Albany Molecular Research Inc. Computer-Aided Drug Introduction
11.3.4 Albany Molecular Research Inc. Revenue in Computer-Aided Drug Business (2019-2024)
11.3.5 Albany Molecular Research Inc. Recent Development
11.4 Charles River Laboratories International Inc.
11.4.1 Charles River Laboratories International Inc. Company Detail
11.4.2 Charles River Laboratories International Inc. Business Overview
11.4.3 Charles River Laboratories International Inc. Computer-Aided Drug Introduction
11.4.4 Charles River Laboratories International Inc. Revenue in Computer-Aided Drug Business (2019-2024)
11.4.5 Charles River Laboratories International Inc. Recent Development
11.5 Chembio Discovery Inc.
11.5.1 Chembio Discovery Inc. Company Detail
11.5.2 Chembio Discovery Inc. Business Overview
11.5.3 Chembio Discovery Inc. Computer-Aided Drug Introduction
11.5.4 Chembio Discovery Inc. Revenue in Computer-Aided Drug Business (2019-2024)
11.5.5 Chembio Discovery Inc. Recent Development
11.6 Chemical Computing Group ULC
11.6.1 Chemical Computing Group ULC Company Detail
11.6.2 Chemical Computing Group ULC Business Overview
11.6.3 Chemical Computing Group ULC Computer-Aided Drug Introduction
11.6.4 Chemical Computing Group ULC Revenue in Computer-Aided Drug Business (2019-2024)
11.6.5 Chemical Computing Group ULC Recent Development
11.7 Compchem Solutions Ltd.
11.7.1 Compchem Solutions Ltd. Company Detail
11.7.2 Compchem Solutions Ltd. Business Overview
11.7.3 Compchem Solutions Ltd. Computer-Aided Drug Introduction
11.7.4 Compchem Solutions Ltd. Revenue in Computer-Aided Drug Business (2019-2024)
11.7.5 Compchem Solutions Ltd. Recent Development
11.8 International Business Machines Corp.
11.8.1 International Business Machines Corp. Company Detail
11.8.2 International Business Machines Corp. Business Overview
11.8.3 International Business Machines Corp. Computer-Aided Drug Introduction
11.8.4 International Business Machines Corp. Revenue in Computer-Aided Drug Business (2019-2024)
11.8.5 International Business Machines Corp. Recent Development
11.9 Kang Yusheng Information Technology Co. Ltd.
11.9.1 Kang Yusheng Information Technology Co. Ltd. Company Detail
11.9.2 Kang Yusheng Information Technology Co. Ltd. Business Overview
11.9.3 Kang Yusheng Information Technology Co. Ltd. Computer-Aided Drug Introduction
11.9.4 Kang Yusheng Information Technology Co. Ltd. Revenue in Computer-Aided Drug Business (2019-2024)
11.9.5 Kang Yusheng Information Technology Co. Ltd. Recent Development
11.10 Openeye Scientific Software Inc.
11.10.1 Openeye Scientific Software Inc. Company Detail
11.10.2 Openeye Scientific Software Inc. Business Overview
11.10.3 Openeye Scientific Software Inc. Computer-Aided Drug Introduction
11.10.4 Openeye Scientific Software Inc. Revenue in Computer-Aided Drug Business (2019-2024)
11.10.5 Openeye Scientific Software Inc. Recent Development
11.11 Pharmaron Beijing Co. Ltd.
11.11.1 Pharmaron Beijing Co. Ltd. Company Detail
11.11.2 Pharmaron Beijing Co. Ltd. Business Overview
11.11.3 Pharmaron Beijing Co. Ltd. Computer-Aided Drug Introduction
11.11.4 Pharmaron Beijing Co. Ltd. Revenue in Computer-Aided Drug Business (2019-2024)
11.11.5 Pharmaron Beijing Co. Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

麻豆原创 Positioning Of Vendors
Aaranya Biosciences Pvt. Ltd.
Albany Molecular Research Inc.
Charles River Laboratories International Inc.
Chembio Discovery Inc.
Chemical Computing Group ULC
Compchem Solutions Ltd.
International Business Machines Corp.
Kang Yusheng Information Technology Co. Ltd.
Openeye Scientific Software Inc.
Pharmaron Beijing Co. Ltd.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.